How to cite item

Osimertinib—first or second line for epidermal growth factor (EGFR) mutation-positive non-small cell lung cancer?

   
@article{JTD24410,
	author = {John A. Green},
	title = {Osimertinib—first or second line for epidermal growth factor  (EGFR) mutation-positive non-small cell lung cancer?},
	journal = {Journal of Thoracic Disease},
	volume = {10},
	number = {Suppl 33},
	year = {2018},
	keywords = {},
	abstract = {Epidermal growth factor (EGFR) M+ non-small cell lung cancer (NSCLC) accounts for about 10% of non-squamous NSCLC in Europe and North America and as much as 40% in women in Asian countries (1).},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/24410}
}